LONGBOARD PHARMACEUTICALS IN's ticker is LBPH and the CUSIP is 54300N103. A total of 52 filers reported holding LONGBOARD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,844,427 | -23.8% | 331,689 | +0.6% | 0.00% | – |
| Q2 2023 | $2,420,049 | +651.8% | 329,707 | +302.5% | 0.00% | – |
| Q1 2023 | $321,890 | +126131.4% | 81,906 | +1.2% | 0.00% | – |
| Q4 2022 | $255 | -99.9% | 80,944 | +0.9% | 0.00% | – |
| Q3 2022 | $298,000 | +534.0% | 80,208 | +416.4% | 0.00% | – |
| Q2 2022 | $47,000 | -39.7% | 15,531 | +2.3% | 0.00% | – |
| Q1 2022 | $78,000 | +6.8% | 15,177 | 0.0% | 0.00% | – |
| Q4 2021 | $73,000 | -45.9% | 15,177 | 0.0% | 0.00% | – |
| Q3 2021 | $135,000 | – | 15,177 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,273,221 | $12,139,000 | 0.93% |
| Integral Health Asset Management, LLC | 47,600 | $254,000 | 0.07% |
| FARALLON CAPITAL MANAGEMENT LLC | 810,500 | $4,328,000 | 0.02% |
| Orbimed Advisors | 113,500 | $606,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 70,000 | $363,000 | 0.01% |
| BAILARD, INC. | 21,200 | $110,000 | 0.00% |
| Alyeska Investment Group, L.P. | 62,500 | $334,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,045,929 | $5,428,000 | 0.00% |
| Veritable, L.P. | 20,534 | $110,000 | 0.00% |
| Laurion Capital Management LP | 20,918 | $109,000 | 0.00% |